Department of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, USA.
STEMCELL Technologies, Vancouver, British Columbia, Canada.
JCI Insight. 2017 Jan 26;2(2):e89906. doi: 10.1172/jci.insight.89906.
Vascular abnormalities are a common component of eye diseases that often lead to vision loss. Vaso-obliteration is associated with inherited retinal degenerations, since photoreceptor atrophy lowers local metabolic demands and vascular support to those regions is no longer required. Given the degree of neurovascular crosstalk in the retina, it may be possible to use one cell type to rescue another cell type in the face of severe stress, such as hypoxia or genetically encoded cell-specific degenerations. Here, we show that intravitreally injected human endothelial colony-forming cells (ECFCs) that can be isolated and differentiated from cord blood in xeno-free media collect in the vitreous cavity and rescue vaso-obliteration and neurodegeneration in animal models of retinal disease. Furthermore, we determined that a subset of the ECFCs was more effective at anatomically and functionally preventing retinopathy; these cells expressed high levels of CD44, the hyaluronic acid receptor, and IGFBPs (insulin-like growth factor-binding proteins). Injection of cultured media from ECFCs or only recombinant human IGFBPs also rescued the ischemia phenotype. These results help us to understand the mechanism of ECFC-based therapies for ischemic insults and retinal neurodegenerative diseases.
血管异常是眼部疾病的常见组成部分,常导致视力丧失。血管闭塞与遗传性视网膜变性有关,因为光感受器萎缩降低了局部代谢需求,这些区域不再需要血管支持。鉴于视网膜中神经血管相互作用的程度,在面临严重应激(如缺氧或遗传编码的细胞特异性变性)时,可能使用一种细胞类型来拯救另一种细胞类型。在这里,我们表明,可从无动物源培养基分离和分化自脐带血的玻璃体内注射人内皮集落形成细胞(ECFC)在视网膜疾病的动物模型中聚集在玻璃体腔中,并挽救血管闭塞和神经退行性变。此外,我们确定了 ECFC 的一个亚群在解剖学和功能上更有效地预防视网膜病变;这些细胞表达高水平的 CD44、透明质酸受体和 IGFBPs(胰岛素样生长因子结合蛋白)。ECFC 培养物的培养基或仅重组人 IGFBPs 的注射也挽救了缺血表型。这些结果帮助我们理解基于 ECFC 的治疗缺血性损伤和视网膜神经退行性疾病的机制。